YOLFTbeta
InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc

INM · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

18.35USD+2.74 (+17.56%)

Price History

Full chart

Market Stats

Previous Close15.61
Open15.75
Day Range14.76 – 19.17
52-Week Range0.575 – 2.50
Volume145.60K
Market Cap7.58M
P/E (TTM)0.00
Forward P/E0.00
EPS-2.84
Dividend Yield0.00%
Beta0.98
50-Day Avg1.45
200-Day Avg1.18

About

InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Eric A. Adams B.S. Chem., M.I.B.
  • Employees6
  • Headquarters500 West Georgia Street, Vancouver, BC, Canada, V6B 0M3, USA
  • Websitehttps://www.inmedpharma.com

Leadership

  • Mr. Eric A. Adams B.S. Chem., M.I.B.President, CEO & Director · b. 1964
  • Ms. N. Netta JagpalCFO & Corporate Secretary · b. 1973
  • Mr. Michael Woudenberg P.Eng.Chief Operating Officer · b. 1970
  • Dr. Eric Chih-Hsien Hsu Ph.D.Senior Vice President of Preclinical Research & Development · b. 1971
  • Dr. Sazzad Hossain M.Sc., Ph.D.Co-Founder · b. 1958
  • Mr. Colin ClancyVP of Investor Relations & Corporate Communications
  • Mr. Jerry P. GriffinVice President of Sales & Marketing
  • Dr. Shane A. Johnson Ph.D.Senior VP & GM of BayMedica

Financials

Income Statement

Currency: USD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue2.44K13.77K185.61K2.09M4.23M2.76M825.79K623.37K168.42K79.46K39.66K-----000001.09M4.14M4.60M4.94M3.18B
Growth (%)-+463.84%+1248.04%+1027.38%+102.27%-34.85%-70.06%-24.51%-72.98%-52.82%-50.09%-----------+279.61%+11.18%+7.50%+64167.28%
Cost of Revenue17.02K17.16K90.02K1.20M3.19M1.42M319.78K405.58K108.89K8.76K27.36K--42.98100.80K85.06K96.12K122.88K123.23K183.09K197.03K545.89K2.73M3.50M3.24M2.47B
Gross Profit-14.58K-3.39K95.59K892.20K1.04M1.34M506.01K217.79K59.53K70.71K12.30K---42.98-100.80K-85.06K-96.12K-122.88K-123.23K-183.09K-197.03K543.55K1.40M1.10M1.71M709.84M
Gross Margin-597.05%-24.65%51.50%42.64%24.60%48.66%61.28%34.94%35.35%88.98%31.01%----------49.89%33.93%23.94%34.53%22.35%
Operating Expense4.24M2.75M1.38M2.13M3.45M2.52M1.65M1.49M836.53K482.11K399.85K--1.23M4.50M2.23M4.28M8.85M13.40M8.97M11.97M14.34M9.78M9.24M9.62M719.74M
Operating Income-4.25M-2.75M-1.28M-1.24M-2.41M-1.18M-1.14M-1.27M-777.00K-411.40K-387.56K-197.13K-49.19K-1.23M-4.60M-2.32M-4.38M-8.98M-13.52M-9.15M-12.17M-13.79M-8.38M-8.13M-7.92M-9.90M
Operating Margin-174165.23%-19989.56%-690.02%-59.38%-56.86%-42.64%-138.42%-203.75%-461.34%-517.73%-977.25%-----------1265.95%-202.60%-176.92%-160.20%-0.31%
EBITDA-2.04M-906.07K-900.07K-946.79K-2.78M-920.79K-973.42K-1.19M-608.24K-341.90K-178.25K-197.13K-46.75K-1.15M-3.38M-1.77M-3.36M-8.85M-10.26M-8.76M-12.17M-18.09M-7.34M-7.06M-7.26M-9.19M
EBITDA Margin-83406.14%-6580.49%-484.92%-45.25%-65.65%-33.39%-117.88%-190.39%-361.14%-430.26%-449.46%-----------1660.34%-177.45%-153.64%-146.80%-0.29%
Net Income-4.27M-2.71M-1.23M-1.52M-2.78M-1.27M-1.87M-922.26K-1.06M-334.79K-325.47K-189.91K-46.74K-1.15M-3.46M-1.84M-3.44M-8.89M-10.01M-8.94M-12.65M-18.60M-7.95M-7.68M-8.16M-12.56M
Net Income Margin-174800.33%-19696.59%-662.88%-72.63%-65.65%-46.14%-226.96%-147.95%-629.28%-421.31%-820.68%-----------1707.32%-192.18%-166.94%-165.14%-0.40%
R&D------204.70K236.23K116.94K118.42K-17.03K-57.87K759.85K292.84K573.72K2.01M4.30M5.81M6.62M7.28M3.73M3.22M2.85M15.13M
R&D as % of Total Revenue------24.79%37.90%69.43%149.02%-----------668.48%90.24%69.98%57.74%0.48%
Interest Expense1.96M32.91K543.33267.57K34.54K81.70K82.14K17.89K5.90K27.63K11.70K16.7110.451.69K3.52K47.92495.1767.17K330.44K18.62K360.35K96.09K-0373.11K10.70K
Interest Expense % of Total Revenue80345.32%239.02%0.29%12.79%0.82%2.96%9.95%2.87%3.50%34.77%29.51%----------8.82%-0.00%7.55%0.00%

Balance Sheet

Currency: USD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets4.67M1.36M1.16M545.89K984.74K651.70K403.26K1.38M25.42K144.72K248.50K47.31K5.09K1.59M1.34M1.28M6.41M21.34M15.07M7.80M12.10M16.46M18.69M16.17M21.23M3.03M
Total Liabilities493.02K74.45K921.99K781.44K1.66M1.14M1.35M1.52M1.05M1.35M46.20K44.59K49.20K70.11K62.51K456.17K284.24K713.02K1.19M1.92M2.97M4.78M2.67M3.58M2.92M1.96M
Total Equity4.18M1.29M241.85K-235.55K-670.63K-485.38K-950.42K-138.98K-1.03M-1.20M202.29K2.72K-44.11K1.52M1.28M820.48K6.13M20.62M13.88M5.88M9.12M11.69M16.02M12.59M18.30M1.08M
Cash41.01K3.58K49.10K14.41K-7.51K47.30K127.78K46.79K--230.53K44.90K4.14K7.11K134.18K41.92K5.16M18.35M9.81M5.81M9.11M7.95M11.81M8.99M15.09M2.19M
Total Debt--65.51K136.21K485.06K114.86K-38.46K57.55K102.17K---------316.98K333.64K1.02M518.92K1.32M1.01M-
Net Debt-41.01K-3.58K16.41K121.80K485.06K67.55K-127.78K-8.33K57.55K102.17K-230.53K-44.90K-4.14K-7.11K-134.18K-41.92K-5.16M-18.35M-9.81M-5.49M-8.77M-6.93M-11.29M-7.67M-14.08M-2.19M

Cash Flow

Currency: USD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-471.69K-1.14M-844.62K-484.19K-702.23K-577.40K-1.40M-951.15K100.48K-195.42K-562.05K-174.62K-39.26K-641.38K-1.61M-386.07K-2.37M-3.68M-8.77M-7.37M-9.79M-15.58M-7.28M-6.99M-7.77M-8.64B
Investing Cash Flow-1.81M1.11M316.70K18.38K-371.63K--10.41K238.09K------2.03K-4.84K-885-19.52K-1.88M-2.76M3.79M-1.73K-673.00K-661.80K-9.29K--
Financing Cash Flow2.21M-572.97K428.40K1.04M648.18K1.48M626.21K-141.50K195.42K792.58K--646.44K1.74M300.14K7.50M19.27M272.50K-30.99K10.85M15.07M10.68M4.65M12.27M94.50M
Capital Expenditure764.01K12.64K24.62K15.45K7.31K012.52K24.85K000002.03K4.84K88519.52K43.80K27.03K42.57K1.73K39.11K161.80K9.29K03
Free Cash Flow-1.24M-1.16M-869.23K-499.64K-709.54K-577.40K-1.41M-976.00K100.48K-195.42K-562.05K-174.62K-39.26K-643.41K-1.61M-386.96K-2.38M-3.72M-6.71M-7.42M-9.79M-15.62M-7.45M-7.00M-7.77M-8.64B
Dividends Paid-------------------------431.66M
FCF to OCF261.97%101.11%102.91%103.19%101.04%100.00%100.90%102.61%100.00%100.00%100.00%100.00%100.00%100.32%100.30%100.23%100.83%101.19%76.48%100.58%100.02%100.25%102.22%100.13%100.00%100.00%
Dividend Paid to FCF--------------------------4.99%

Earnings

Report DateFeb 28, 2014May 28, 2014Jun 30, 2014Oct 28, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Nov 29, 2016Feb 27, 2017Apr 1, 2017Jun 30, 2017Nov 20, 2017Feb 22, 2018May 11, 2018Sep 13, 2018Nov 12, 2018Feb 12, 2019May 15, 2019Sep 19, 2019Nov 8, 2019Feb 14, 2020May 14, 2020Sep 8, 2020Dec 17, 2020Feb 11, 2021May 13, 2021Sep 24, 2021Nov 10, 2021Feb 14, 2022May 13, 2022Sep 23, 2022Nov 15, 2022Feb 17, 2023May 15, 2023Sep 29, 2023Nov 14, 2023Feb 13, 2024May 14, 2024Sep 27, 2024Nov 12, 2024Feb 11, 2025May 12, 2025Sep 29, 2025Nov 13, 2025Feb 12, 2026May 18, 2026Sep 28, 2026Nov 5, 2026
EPS Estimate----------------------165.00-0.66-330.00-330.00-330.00-330.00-16.50-153.50-152.50-8.50-222.00-149.50-159.50-5.50-108.50-4.50-4.50-4.25-0.22-5.50-0.18----------
EPS Actual-0.04-0.09-453.79-0.48-201.27-528.16-421.76-155.68-159.25-75.46-107.29-0.15-0.25-0.27-180.36-0.37-0.30-0.37-0.50-0.42-0.39-330.00-0.66-330.00-330.00-330.00-1105.00-0.34-185.00-205.00-10.25-155.49-197.45-161.65-14.03-107.86-0.91-0.60-3.25-0.10-14.03-0.18-0.22-0.22-3.64-1.94-1.20-0.44-0.51-0.73-1.43-
Surprise----------------------100.00%0.00%0.00%0.00%0.00%-234.85%97.94%-20.52%-34.43%-20.59%29.96%-32.07%-1.35%-155.09%0.59%79.78%86.67%23.53%53.77%-155.09%0.44%----------
TimingAfter-hoursAfter-hours-After-hours-------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours----After-hours

Key Statistics & Ratios

Market Cap7.58M
Enterprise Value5.39M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.89
Price / Book7.05
EPS-2.84
Book Value0.201
Revenue (TTM)4.94M
Gross Profit (TTM)1.71M
EBITDA-9.69M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-156.77%
Return on Assets-66.46%
Shares Outstanding5.49M
Shares Float3.13M
Beta0.98
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
52.73%
Insiders
0.06%
Retail / Other
47.21%

Top Institutional Holders

  • Vivo Capital, LLC
    798.38K14.95%
  • Squadron Capital Management LLC
    325.00K6.09%
  • Sabby Management LLC
    220.26K4.13%
  • Citadel Advisors Llc
    26.08K0.49%
  • SEVEN GRAND MANAGERS, LLC
    25.00K0.47%
  • Virtu Financial LLC
    19.98K0.37%
  • TWO SIGMA SECURITIES, LLC
    18.72K0.35%
  • Stratos Wealth Partners, LTD
    10.76K0.20%
  • UBS Group AG
    8.07K0.15%
  • Private Wealth Management Group LLC
    5.00K0.09%
  • SBI Securities Co Ltd
    3000.01%
  • Banque Cantonale Vaudoise
    60.00%
  • Federation des caisses Desjardins du Quebec
    20.00%
  • Susquehanna International Group, LLP
    00.00%
  • Jane Street Group LLC
    00.00%

Top Fund Holders

  • AdvisorShares Pure Cannabis ETF
    16.43K1.36%

Stock Splits

  • Nov 5, 20261:10
  • Nov 14, 20241:20
  • Sep 7, 20221:25
  • Jul 6, 20201:33